1. Home
  2. WBX vs VYGR Comparison

WBX vs VYGR Comparison

Compare WBX & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$3.09

Market Cap

65.2M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.09

Market Cap

216.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WBX
VYGR
Founded
2015
2013
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.2M
216.3M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
WBX
VYGR
Price
$3.09
$3.09
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.75
$16.50
AVG Volume (30 Days)
10.7K
404.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$18.10
$34.04
Revenue Next Year
$94.11
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$2.94
52 Week High
$7.83
$5.55

Technical Indicators

Market Signals
Indicator
WBX
VYGR
Relative Strength Index (RSI) 47.29 42.00
Support Level $2.77 $2.95
Resistance Level $3.19 $3.30
Average True Range (ATR) 0.18 0.14
MACD 0.06 -0.03
Stochastic Oscillator 31.88 13.19

Price Performance

Historical Comparison
WBX
VYGR

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: